Imagion Biosystems Limited (ASX:IBX)
0.0130
-0.0010 (-7.14%)
Apr 24, 2025, 3:45 PM AEST
Imagion Biosystems Balance Sheet
Financials in millions AUD. Fiscal year is January - December.
Millions AUD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Cash & Equivalents | 2.67 | 0.23 | 4.45 | 13.39 | 13.2 | Upgrade
|
Cash & Short-Term Investments | 2.67 | 0.23 | 4.45 | 13.39 | 13.2 | Upgrade
|
Cash Growth | 1076.00% | -94.89% | -66.81% | 1.46% | 288.06% | Upgrade
|
Accounts Receivable | 0 | 0.07 | 0.09 | 0.03 | - | Upgrade
|
Other Receivables | 0.03 | 0.03 | 0.02 | 0.03 | 0.07 | Upgrade
|
Receivables | 0.03 | 0.1 | 0.11 | 0.06 | 0.07 | Upgrade
|
Prepaid Expenses | 0.08 | 0.14 | 0.32 | 0.17 | 0.13 | Upgrade
|
Other Current Assets | - | 0.13 | 0.11 | 0.14 | 0.04 | Upgrade
|
Total Current Assets | 2.79 | 0.6 | 4.99 | 13.77 | 13.43 | Upgrade
|
Property, Plant & Equipment | 0.02 | 3.98 | 4.99 | 0.35 | 0.69 | Upgrade
|
Total Assets | 2.8 | 4.59 | 9.98 | 14.12 | 14.12 | Upgrade
|
Accounts Payable | 2.07 | 1.59 | 0.33 | 0.43 | 0.29 | Upgrade
|
Accrued Expenses | - | 0.26 | 0.18 | 0.14 | 0.11 | Upgrade
|
Current Portion of Long-Term Debt | 2.79 | 1.7 | - | - | - | Upgrade
|
Current Portion of Leases | 0.05 | 1.1 | 1.04 | 0.02 | 0.36 | Upgrade
|
Other Current Liabilities | 0.17 | 0.48 | 0.19 | 0.19 | 0.15 | Upgrade
|
Total Current Liabilities | 5.09 | 5.13 | 1.73 | 0.78 | 0.9 | Upgrade
|
Long-Term Debt | - | 0.75 | - | - | - | Upgrade
|
Long-Term Leases | - | 2.49 | 3.56 | 0.03 | 0.3 | Upgrade
|
Total Liabilities | 5.09 | 8.37 | 5.3 | 0.81 | 1.21 | Upgrade
|
Common Stock | 62.54 | 59.61 | 56.83 | 56.83 | 51.32 | Upgrade
|
Retained Earnings | -67.01 | -68.32 | -55.84 | -46.03 | -40.01 | Upgrade
|
Comprehensive Income & Other | 2.19 | 4.92 | 3.69 | 2.51 | 1.6 | Upgrade
|
Shareholders' Equity | -2.28 | -3.79 | 4.68 | 13.31 | 12.91 | Upgrade
|
Total Liabilities & Equity | 2.8 | 4.59 | 9.98 | 14.12 | 14.12 | Upgrade
|
Total Debt | 2.85 | 6.04 | 4.6 | 0.05 | 0.66 | Upgrade
|
Net Cash (Debt) | -0.18 | -5.81 | -0.16 | 13.35 | 12.54 | Upgrade
|
Net Cash Growth | - | - | - | 6.44% | 396.63% | Upgrade
|
Net Cash Per Share | -0.00 | -0.19 | -0.01 | 0.51 | 0.67 | Upgrade
|
Filing Date Shares Outstanding | 201.34 | 32.65 | 28.03 | 28.03 | 25.69 | Upgrade
|
Total Common Shares Outstanding | 201.34 | 32.65 | 28.03 | 28.03 | 24.96 | Upgrade
|
Working Capital | -2.3 | -4.53 | 3.26 | 12.99 | 12.53 | Upgrade
|
Book Value Per Share | -0.01 | -0.12 | 0.17 | 0.47 | 0.52 | Upgrade
|
Tangible Book Value | -2.28 | -3.79 | 4.68 | 13.31 | 12.91 | Upgrade
|
Tangible Book Value Per Share | -0.01 | -0.12 | 0.17 | 0.47 | 0.52 | Upgrade
|
Machinery | 0.11 | 1.28 | 1.1 | 0.86 | 0.75 | Upgrade
|
Leasehold Improvements | - | 0.55 | 0.56 | 0.24 | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.